Oric Pharmaceuticals Inc at Citi Virtual Oncology Leadership Summit Transcript
All right. Great. Welcome back, everyone. I think everyone knows me. I'm Yigal Nochomovitz, one of the biotech analysts at Citi. This is the second day of Citi's Virtual Oncology Leadership Summit. It's great to have the senior management of ORIC here, Jacob Chacko and Pratik Multani. Thank you both so much for joining. We really appreciate the time.
Questions & Answers
Maybe, Jacob, if you want to just kick it off with the high-level introduction to ORIC. What's the business strategy? What are you focused on? A little bit on the 3 clinical stage programs that you're running right now? And some of the -- just your thoughts conceptually on how you select targets and your approach to drug development?
Sure thing, Yigal. There's a lot wrapped up in that. Thank you for having us today. We appreciate
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |